GlobeNewswire (press release)Incysus to Present Scientific Overview at the 2018 CAR-T Congress USA MeetingGlobeNewswire (press release)NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) — Incysus, Ltd., a biopharmaceutical company focused on delivering an inno… Continue reading
GlobeNewswire (press release)Incysus to Present Scientific Overview at the 2018 CAR-T Congress …GlobeNewswire (press release)Dr. Lawrence Lamb to Present Adoptive Gamma-Delta T Cell Immunotherapy as a Strategy for Eliminating Residual Malignancy.and … Continue reading
BakeryAndSnacks.com |
TechAccel partners with UC Davis to develop heat-stable wheat enzymes to improve global yield affected by climate …
BakeryAndSnacks.com Non-GMO wheat. “If we are successful in demonstrating the enzyme’s effectiveness, the next step will be to employ gene editing to produce a non-GMO wheat with significantly improved yield,” said Dr Fabbri, noting the first bags of seed would possibly … |
|
Oncolytics Biotech® Scientist Selected to Participate in the Society of Immunotherapy of Cancer’s (SITC) METIOR …
Marketwired (press release) CALGARY, AB and SAN DIEGO, CA–(Marketwired – March 20, 2018) – Oncolytics Biotech® Inc. (TSX: ONC) ( OTCQX : ONCYF), a biotech company developing REOLYSIN® (pelareorep), an intravenously delivered immuno-oncolytic virus creating an inflamed phenotype … |
|
Bayer, Ginkgo Bioworks names new tech partnership Joyn Bio
AGDAILY Joyn Bio will be digging into some of the latest advancements in synthetic biology for agriculture. Never heard of Joyn Bio? Don’t worry, until today, no one else had either. The name belongs to the new technology partnership announced between Bayer … |